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Abstract
Background: Combining information from different studies is an important and useful practice in bioinformatics,
including genome-wide association study, rare variant data analysis and other set-based analyses. Many statistical
methods have been proposed to combine p-values from independent studies. However, it is known that there is
no uniformly most powerful test under all conditions; therefore, finding a powerful test in specific situation is
important and desirable.
Results: In this paper, we propose a new statistical approach to combining p-values based on gamma distribution,
which uses the inverse of the p-value as the shape parameter in the gamma distribution.
Conclusions: Simulation study and real data application demonstrate that the proposed method has good
performance under some situations.
Background
To combine information from individual studies, many
statistical approaches have been proposed. For example,
meta-analysis with fixed or random effects has been
intensively used to combine information from separate
relevant genome-wide association studies (GWASs).
However, in practice sometimes it may not be able to get
all the statistics that we need, such as odds ratio and its
95% confidence interval; instead, only p-value from each
study is available. In this case, combining p-values from
independent studies should be used. In the literature,
many statistical methods have been proposed to combine
p-values [1-14]. For example, it has been shown that the
Fisher test is more robust than the z-test and is com-
monly used for genetic data [15-26]. On the other hand,
if the effects have the same direction and/or similar sizes,
z-test is more powerful than the Fisher test. Some studies
have shown that the weighted z-tests with weight equals
to the sample size or the inverse of the standard error
may perform better than the unweighted z-test under
certain situations [27]. However, it has also been shown
that there is no uniformly most powerful method [1].
Therefore, it is desirable to find a test which is more
powerful than others for given situations. For instance, in
GWAS meta-analysis, it is very common that the genetic
effects of the same single-nucleotide polymorphism
(SNP) from different studies are heterogeneous due to
various environmental factors and study populations.
Therefore, the fixed effect model cannot be applied and a
p-value combining method is preferred.
Lancaster generalized Fisher test by giving certain
degrees of freedom to individual studies when combine
p-values based on the chi-square distribution. When the
degrees of freedom (df) equal to two for each study,
Lancaster’s test is identical to the Fisher test. Recently,
Chen and Nadarajah have studied another special case
of Lancaster’s test where the df is one for each study
[14]. They have shown that their test can also be viewed
as a weighted z-test with the “weight” equals to the esti-
mated effect, defined as the estimated mean difference
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divided by the estimated standard error, which can be
calculated by |−1 (pi) | , where pi is the one-sided p-
value from the ith study and −1(.) is the inverse of the
cumulative density function (CDF) of the standard nor-
mal distribution, N(0,1).
Methods based on the gamma distribution (GDM) are
also available in the literature. In fact, Lancaster’s meth-
ods are special cases of GDMs. GDMs are more flexible
and potentially can be more powerful in some situations
when appropriate parameters (e.g., the shape parameter
in the gamma distribution) are chosen. However, it is
usually difficult to set appropriate parameters before we
see the data. In this paper, we propose a GDM, which
adaptively chooses the shape parameter of the gamma
distribution for each individual study. We compare the
performance of the proposed test with existing methods
through simulation studies. We also use real data appli-
cation to illustrate the use of the new approach.
Methods
Suppose we have K independent studies and their asso-
ciated p-values pi (i = 1,2,...,K). Under the null hypoth-
esis that there is no effect for all studies, the p-values
from individual studies are uniformly distributed
between 0 and 1. The weighted z-tests are formulated as
follows:
ZW =
k∑
i=1
wi−1(pi)/
√√√√ k∑
j=1
w2j . (1)
where wi is the weight for study i. When all wi = 1,
the above test is the unweighted z-test, also called the
Stouffer test [5]. When wi = ni, where ni is the sample
size for study i , it is called the Mosteller-Bush test [8].
Other researchers suggested the use of the square root
of the sample size
√
ni or the inverse of the estimated
standard error 1/ŝe as weight [27].
Other ways to combine p-values are based on the fol-
lowing property: if Y1,Y2, . . . ,YK are K independent
random variables and each has a chi-square distribution
with df equal to di, then their sum has a chi-square dis-
tribution with df equal to the sum of their df’s. Fisher
[9] found that if K random variables X1,X2, . . . ,XK are
independent and identically uniformly distributed
between 0 and 1, then each −2 log(Xi) has a chi-square
distribution with df = 2 and their sum −2
k∑
i=1
log(Xi)
has a chi-square distribution with 2K df, χ2(df = 2k) .
Based on this fact, Fisher used test statistic
χ2(df = 2k) and compared it to χ2(df = 2k) to calcu-
late the overall p-value. Lancaster [3] generalized Fish-
er’s test by giving different di df for each study. The test
statistic under the null hypothesis has a χ2(df =
k∑
i=1
di).
More specifically, the test statistic is given by:
K∑
i=1
F−1i (1 − pi), (2)
where F−1i is the inverse of χ
2(df = di) .
Rather than the chi-square distribution, a more gener-
alized distribution, gamma distribution, can be used.
The test statistic based on the gamma distribution can
be written as:
T =
∑K
i=1 G
−1
αiβ
(1 − pi), (3)
where G−1αiβ(.) is the inverse gamma distribution with
shape parameter ai and scale parameter b. Due to the
property of the gamma distribution, for constant shape
parameter ai, T will have a gamma distribution with
shape parameter equals to
∑K
i=1 αi and scale parameter
equals to b. When all ai = 1, T has an exponential dis-
tribution under the null hypothesis. When all ai = v/2
and b = 2, the null distribution of T is a chi-square dis-
tribution with df = vK . When v = 1, it is the Chen-
Nadarajah test [14]; when v = 2, it is the Fisher test.
In this paper, we use b = 1 as the scale parameter
which has no effect on power of the test T. For the
shape parameter, we will use αi = 1/pi for the i
th study.
So the proposed test statistic is:
T =
∑K
i=1 G
−1
1/pi
(1 − pi), (4)
Notice that since the gamma distribution with shape
parameter ai and scale parameter 1 has expected value
ai, a small p-value of pi results in a large expected
value. Therefore, the proposed test gives larger “weights”
to smaller p-values. In addition, since pi is a random
variable, the proposed test doesn’t follow a gamma dis-
tribution any more. However, the p-value can be easily
estimated by resampling method. Under the null
hypothesis, pi is uniformly distributed between 0 and 1.
For the given number of studies, K, we can generate K
numbers from uniform distribution U(0,1) and then cal-
culate the statistic t defined in (4). We repeat this step
N times (say, N = 108), then the null distribution of T
can be approximated by those numbers and the p-value
can be estimated by the proportion of the N values
which are greater than the observed statistic.
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Results
Simulation study
To assess the performance of the proposed test, we con-
duct a simulation study by comparing it with some exist-
ing methods, including the z-test (denoted by Z),
weighted z-tests with weights equal to the sample size
(Z_n) or the estimated standard error (Z_se), the Chen-
Nadarajah (CN) method, the Fisher test (Fisher). In the
simulation study, we assume there are K independent
studies, where K = 2, 10, or 100. For each study, we simu-
late data from two normal distributions: N(0, σ 2) , and
N(μi, σ 2) with sample sizes n1 = n2 = n, respectively. Of
the K studies, there are different numbers of studies that
have none-zero effects (i.e.,μi = 0 ), which may have dif-
ferent values among studies but their sum is a constant.
We consider several conditions for allocating effect sizes
among the K studies. We first consider sample sizes and
variances are fixed. We then assume the sample size, or
the variance, or both the sample size and the variance are
randomly sampled from given distributions. For random
sample size, we assume it follows a Poisson distribution,
Poi(l); for random variances, we assume the standard
deviation follows a gamma distribution with shape para-
meter a and scale parameter b, gamma(a, b). A p-value
from a two-sample t-test to compare two group means
for each study is obtained and is used to combine those
K studies. When K is small (i.e., 2, and 10), we consider
situations where there are 1 to K studies having none-
zero effects. For K = 100, we consider i (i = 1, 2,..., 10)
studies having the same effect size while the remaining
100-i studies having zero effect. We choose significance
level 0.05 in the simulation study and use 105 replicates
to estimate the type I error rate and the power.
Simulation results
All the methods can control type I error rate (data not
shown). Figure 1 plots the power values for each method
when there are only two studies (K = 2) with the sum of
Figure 1 Power values for each method under six different conditions: the total effect size is 1 and the ratios of the K = 2 effect sizes
between study 1 and study 2 are 0, 0.01, 0.05, 0.1, 0.5, and 1. (a) Sample sizes n = 20, and standard deviation s = 1 for each study; (b)
Same as (a), but the sample size n is a random sample from Poi(20); (c) Same as (a), but the standard deviation s is a random sample from
gamma(10, 0.1); (d) Same as (b), but the standard deviations s is a random sample from gamma(10, 0.1).
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the two effect sizes equals to 1. Six conditions are consid-
ered: the ratios of the effects sizes between study1 and
study 2 are 0, 0.01, 0.05, 0.1, 0.5, and 1, respectively.
Therefore, the heterogeneity of effects between the two
studies decreases from condition 1 to condition 6. Figure
1 (a) shows that the gamma-distribution based methods
(Fisher, CN, and New) perform similarly, and all outper-
form the Z-based methods (Z, Z_n, Z_se) when the
effects are not homogenous between the two studies
(conditions 1 to 5). When the two studies have the same
effect size (condition 6), the power values from all meth-
ods are close to each other. We have similar observations:
when the sample size is randomly sampled from Poisson
distribution Poi(20) (Figure 1 (b)), or when the standard
deviation is randomly sampled from gamma distribution,
gamma(10, 0.1) (Figure 1 (c)), or when both sample
sizes and standard deviations are random samples as in
Figure 1 (b) and 1(c) (Figure 1 (d)).
Figure 2 plots the estimated power values for each
method when there are i (i = 1,2,..., 10) studies having
none-zero effects and the sum of those effect sizes is 2.
For those i studies with none-zero effects, we assume the
mean of the second group equals to 2/i. Figure 2 (a)
shows that when only a few studies have none-zero
effects (e.g., i = 1, 2, 3) the gamma-distribution based
methods, including the proposed test perform better
than those Z-based methods. However, when the effects
among those studies become more homogenous, the pro-
posed test has slightly lower power values. The sample
size n = 20 and standard deviation s = 1 are assumed for
each study in Figure 2 (a). We have similar observations
when sample size n is a random sample from Poi(20)
(Figure 2 (b)), or when standard deviation s is randomly
sampled from a gamma(10, 0.1) (Figure 2 (c)), or when
both sample size and standard deviation are random
samples as in Figure 2 (b) and 2(c) (Figure 2 (d)).
Figure 2 Power values for each method under 10 different conditions: for situation i, there are i out of K = 10 studies each has the
same effect size 2/i and the remaining 10-i studies have zero effect. (a) Sample size n = 20, and standard deviation s = 1 for each study;
(b) Same as (a), but the sample size n is a random sample from Poi(20); (c) Same as (a), but the standard deviation s is a random sample from
gamma(10, 0.1); (d) Same as (b), but standard deviation s is a random sample from gamma(10, 0.1).
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Figure 3 plots the power values for each method when
there are 100 independent studies but only i(i = 1, 2,...,
10) studies have none-zero effect sizes. For those i stu-
dies with none-zero effects, we assume the mean for the
second group equals to 2/i. In Figure 3 (a) we set sam-
ple size n = 20 and s = 1 for each study. When there
are only one or two studies having none-zero effects,
the proposed test has much higher power values than
the Fisher test and the CN method, which in turn are
more powerful than the Z, Z_n, and Z_se tests. When
the number of significant studies increases, all of the
methods have close power values. The same pattern can
be observed when n is random samples from Poi(20)
(Figure 3 (b)), or when s is randomly sampled from a
gamma(10, 0.1) (Figure 3 (c)), or when both sample size
and standard deviation are random samples as in Figure
3 (b) and 3(c) (Figure 3 (d)).
Real data application
We apply the proposed approach to a meta-analysis of
Genome-wide association study (GWAS). The data
include 5 independent case-control studies where we
wanted to test whether there is an association between
the SNP rs17110747-A and major depression [28].
Table 1 is the count data from these studies. The 5 p-
values are 0.94, 0.0015, 0.97, 0.79, and 0.81. The overall
p-values from the Z, Z_n, Z_se, Fisher, CN, and the
proposed test are 0.84, 0.53, 0.29, 0.17, 0.062, and
0.0081, respectively. Only the proposed test has p-value
less than 0.05.
Discussion and conclusions
Combining information from individual studies is an
important and useful tool, especially for set-based
approaches. For example, in studying the effect of rare
Figure 3 Power values for each method under 10 different conditions: for situation i, there are i out of K = 100 studies each has the
same effect size 2/i and the remaining 100-i studies have zero effect. (a) Sample size n = 20, and standard deviation s = 1 for each study;
(b) Same as (a), but the sample size n is a random sample from Poi(20); (c) Same as (a), but the standard deviation s is a random sample from
gamma(10, 0.1); (d) Same as (b), but the standard deviation s is a random sample from gamma(10, 0.1).
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variants on diseases, a set of rare variants are tested
simultaneously, and their p-values are combined to test
for the association between the rare variants and the
disease [29]. However, most of the rare variants may
have no or little effects while a few of them may have
large effects. In this case, the proposed test will be more
powerful than other methods if combining p-value
methods are used. However, it should be pointed out
that, the rare variants from a set (e.g., gene) maybe corre-
lated, and the proposed test needs to be modified accord-
ingly. A permutation-based test can be applied to
estimate the p-value. We first calculate the statistic based
on the proposed test (4). Then we permute the disease
status (case or control); for each permutation, we use the
proposed test to calculate a statistic. After a large number
of permutations, the p-value will be estimated as the pro-
portion of the statistics from the permutations excessing
the observed statistic from the original data. To assess
the performance of the proposed test in rare variant asso-
ciation studies, real data are needed. This will be a topic
of our future research.
As mentioned earlier, no method is uniformly most
powerful when combing p-values. However, based on
our simulation studies, the proposed test is more power-
ful when the effects among the studies are more hetero-
geneous. When the effects are homogeneous, perhaps
the Z-based tests are more powerful. Without the infor-
mation about the effect sizes, robust methods, such as
the CN and Fisher tests are recommended.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ZC and MQY conceived and guided the project. ZC designed the project
and conducted the study. WY, QL, JL, and JYY participated in the study
through computational implementation, data analysis and discussions. ZC
wrote the manuscript, and ZC and MQY finalized the manuscript, which was
read and approved by all authors.
Acknowledgements
The research was supported by Indiana University Institutional Research
Awards and National Institutes of Health (NIH). ZC would like to thank the
institutional faculty research grant awards from the Indiana University
Bloomington School of Public Health. MQY would like to thank the support
from NIH/NIGMS 5P20GM10342913 and ASTA Award # 15-B-23.
Declaration
The funding for publication of the article has come from Indiana University
Bloomington institutional research grant awards to ZC.
This article has been published as part of BMC Bioinformatics Volume 15
Supplement 17, 2014: Selected articles from the 2014 International
Conference on Bioinformatics and Computational Biology. The full contents
of the supplement are available online at http://www.biomedcentral.com/
bmcbioinformatics/supplements/15/S17.
Authors’ details
1Department of Epidemiology and Biostatistics, Indiana University School of
Public Health, 1025 E. 7th street, PH C104, Bloomington, Indiana, 47405, USA.
2Department of Computer Science, George W. Donaghey College of
Engineering and Information Technology, University of Arkansas at Little
Rock, 2801 S. University Avenue, Little Rock, Arkansas 72204, USA.
3Department of Computer Science, Sam Houston State University, Huntsville,
Texas 77341, USA. 4Center for Compuational Biology and Bioinformatics,
Indiana University School of Medicine, Indianaplois, Indiana, 46202, USA.
5Division of Biostatistics and Biomathematics, Massachusetts General Hospital
and Harvard Medicial School, Boston, Massachusetts 02114, USA. 6MidSouth
Bioinformatics Center, Department of Information Science, George W.
Donaghey College of Engineering and Information Technology, University of
Arkansas at Little Rock, 2801 S. University Avenue, Little Rock, Arkansas,
72204, USA. 7Joint Bioinformatics Graduate Program, University of Arkansas
at Little Rock and University of Arkansas for Medical Sciences, Little Rock,
Arkansas 72204, USA.
Published: 16 December 2014
References
1. Birnbaum A: Combining independent tests of significance. J Amer Statist
Assoc 1954, 49(267):559-574.
2. Good IJ: On the weighted combination of significance tests. J R Stat Soc
Ser B Stat Methodol 1955, 17(2):264-265.
3. Lancaster H: The combination of probabilities: an application of
orthonormal functions. Austral J Statist 1961, 3:20-33.
4. Pearson ES: The probability integral transformation for testing goodness
of fit and combining independent tests of significance. Biometrika 1938,
30(1/2):134-148.
5. Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RMJ. In: The
American Soldier, Vol 1: Adjustment during Army Life Princeton: Princeton
University Press; 1949.
6. Tippett L: The Methods of Statistics London: Williams and Norgate Ltd; 1931.
7. Whitlock MC: Combining probability from independent tests: the
weighted Z-method is superior to Fisher’s approach. J Evol Biol 2005,
18(5):1368-1373.
8. Mosteller F, Bush RR: Selected quantitative techniques. In Handbook of
Social Psychology. Mass: Addison-Wesley;Lindzey G. Cambridge
1954:289-334.
9. Fisher RA: Statistical Methods for Research Workers Edinburgh: Oliver and
Boyd; 1932.
10. Liptak T: On the combination of independent tests. Magyar Tud Akad Mat
Kutato Int Kozl 1958, 3:171-197.
11. Chen Z, Nadarajah S: Comments on ‘Choosing an optimal method to
combine p - values’ by Sungho Won, Nathan Morris, Qing Lu and
Robert C. Elston, Statistics in Medicine 2009; 28: 1537-1553. Statistics in
Medicine 2011, 30(24):2959-2961.
12. Chen Z: Is the weighted z - test the best method for combining
probabilities from independent tests? Journal of Evolutionary Biology 2011,
24(4):926-930.
13. Loughin TM: A systematic comparison of methods for combining
p-values from independent tests. Computational statistics & data analysis
2004, 47(3):467-485.
14. Chen Z, Nadarajah S: On the optimally weighted z-test for combining
probabilities from independent studies. Computational Statistics & Data
Analysis 2014, 70:387-394.
15. Chen Z: A new association test based on Chi - square partition for case -
control GWA studies. Genetic Epidemiology 2011, 35(7):658-663.
Table 1 Count data from the five independent studies
investigating the association between SNP rs17110747-A
and major depression
study case control
event total event total
1 11 270 25 630
2 244 1016 282 926
3 49 234 35 166
4 79 600 76 600
5 71 290 86 340
Chen et al. BMC Bioinformatics 2014, 15(Suppl 17):S3
http://www.biomedcentral.com/1471-2105/15/S17/S3
Page 6 of 7
16. Chen Z: Association tests through combining p-values for case control
genome-wide association studies. Statistics and Probability Letters 2013,
83(8):1854-1862.
17. Chen Z, Huang H, Liu J, Ng HKT, Nadarajah S, Huang X, Deng Y: Detecting
differentially methylated loci for Illumina Array methylation data based
on human ovarian cancer data. BMC Medical Genomics 2013, 2013,
6(Suppl 1):S9.
18. Chen Z, Huang H, Ng HKT: Design and Analysis of Multiple Diseases
Genome-wide Association Studies without Controls. GENE 2012,
510(1):87-92.
19. Chen Z, Huang H, Ng HKT: Testing for Association in Case-Control
Genome-wide Association Studies with Shared Controls. Statistical
Methods in Medical Research, Published online before print February 1, 2013,
doi: 101177/0962280212474061 2013.
20. Chen Z, Liu Q, Nadarajah S: A new statistical approach to detecting
differentially methylated loci for case control Illumina array methylation
data. Bioinformatics 2012, 28(8):1109-1113.
21. Chen Z, Ng HKT: A Robust Method for Testing Association in Genome-
Wide Association Studies. Human Heredity 2012, 73(1):26-34.
22. Huang H, Chen Z, Huang X: Age-adjusted nonparametric detection of
differential DNA methylation with case–control designs. BMC
Bioinformatics 2013, 14(1):86.
23. Chen Z, Ng HKT, Li J, Liu Q, Huang H: Detecting associated single-
nucleotide polymorphisms on the × chromosome in case control
genome-wide association studies. Statistical methods in medical research
2014, Published online before print September 24, 2014, doi: 2010.1177/
0962280214551815.
24. Chen Z, Huang H, Ng HKT: An Improved Robust Association Test for
GWAS with Multiple Diseases. Statistics & Probability Letters 2014,
91:153-161.
25. Chen Z, Huang H, Liu Q: Detecting differentially methylated loci for
multiple treatments based on high-throughput methylation data. BMC
Bioinformatics 2014, 15:142.
26. Chen Z: A new association test based on disease allele selection for
case-control genome-wide association studies. BMC Genomics 2014,
15:358.
27. Zaykin D: Optimally weighted Z - test is a powerful method for
combining probabilities in meta - analysis. Journal of Evolutionary Biology
2011, 24(8):1836-1841.
28. Gao J, Pan Z, Jiao Z, Li F, Zhao G, Wei Q, Pan F, Evangelou E: TPH2 gene
polymorphisms and major depression-a meta-analysis. PloS one 2012,
7(5):e36721.
29. Chen LS, Hsu L, Gamazon ER, Cox NJ, Nicolae DL: An exponential
combination procedure for set-based association tests in sequencing
studies. The American Journal of Human Genetics 2012, 91(6):977-986.
doi:10.1186/1471-2105-15-S17-S3
Cite this article as: Chen et al.: A new statistical approach to combining
p-values using gamma distribution and its application to genome-wide
association study. BMC Bioinformatics 2014 15(Suppl 17):S3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Chen et al. BMC Bioinformatics 2014, 15(Suppl 17):S3
http://www.biomedcentral.com/1471-2105/15/S17/S3
Page 7 of 7
